Zyvox

Type: Product
Name: Zyvox
First reported Oct 30 2014 - Updated Oct 31 2014 - 1 reports

Attorney General's office counters claims by New York Times

2:36 PM by Lee Anne Denyer, KOMU 8 Digital ProducerUpdated: Oct 30, 2014 2:36 PMJEFFERSON CITY - The Attorney General's office released documents Thursday designed to show the New York Times misrepresented actions by Attorney General Chris Koster in two ... [Published KOMU - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 30 2014 - 1 reports

Market Update (NYSE:PFE): Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder

[Business Wire] – Pfizer Inc. today announced the publication of a clinical study in the Journal of Clinical Psychiatry showing comparable sexual function in adult patients diagnosed with major depressive disorder treated daily with PRISTIQ Extended Release ... [Published Jutia Group - Oct 29 2014]
First reported Oct 30 2014 - Updated Oct 30 2014 - 1 reports

Two New Antibiotics Treat Severe Skin Infections

MS, RNAbstract* Two new antibiotics, tedizolid (Sivextro) and oritavancin (Orbactiv), were recently approved to treat serious skin and skin-structure infections.* Tedizolid is given for six days either orally or intravenously. The most common adverse ... [Published American Journal of Nursing - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 1 reports

Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off

Source: Flickr user David Goehring.Big pharmaceutical companies are in the midst of dealing with the most sweeping patent cliff in their history, and Pfizer ( NYSE: PFE     ) is still dangling on the edge.Having lost Lipitor, Viagra, and a number of ... [Published Motley Fool Discussion Boards - Oct 29 2014]
First reported Oct 28 2014 - Updated Oct 28 2014 - 1 reports

Pfizer Q3 net income up 3%, guidance updated

News EditorPfizer (NYSE:PFE) Q3 results ($M): Total Revenues: 12,361 (-2.2%); GIP: 3,490 (-4.1%); VOC: 2,511 (+13.4%); GEP: 6,239 (-6.5%); Other: 121 (+7.1%).COGS: 2,368 (+3.5%); R&D Expense: 1,802 (+10.8%); SI&A Expense: 3,556 (+4.7%); Net Income: 2,666 ... [Published Seeking Alpha - Oct 28 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Company Update (NYSE:PFE): Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend

[Business Wire] – The board of directors of Pfizer Inc. today declared a 26-cent fourth-quarter 2014 dividend on the company’s common stock, payable December 2, 2014, to shareholders of record at the close of business on November 7, 2014.Read more on ... [Published Jutia Group - Oct 24 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 1 reports

The battle against Big Pharma for cheap drugs

Sulaiman PhilipSection 27 of the South African Constitution guarantees everyone the right to access to health care. However, the government has not been able to follow the success of its antiretroviral (ARV) programme with similar programmes for other ... [Published MediaClubSouthAfrica.com - Oct 22 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

Actavis expands antibiotics

The specialty-drug giant is acquiring biotech startup Durata Therapeutics (DRTX) for $675 mil in cash. Durata has just 1 product, Dalvance, an antibiotic for acute bacterial skin infections, given intravenously twice over 2 weeks. The drug was approved ... [Published Yahoo! Finance - Oct 07 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

Patients break law to get TB drug

Cape Town - The high cost of drugs for extensively drug-resistant tuberculosis (XDR-TB) has led some medical aid schemes to be selective in providing coverage and left patients with a tough choice: break the law or die.During the dark days of Aids denialism, ... [Published IOL - Oct 02 2014]
First reported Sep 28 2014 - Updated Sep 28 2014 - 1 reports

buy Zyvox no rx, Zyvox where to buy, Zyvox with no prescription

Order Zyvox NOW and get free pills!!!Zyvox (Synonyms: Linezolid)price for Zyvox... drug Zyvox, buy Zyvox cod, drug Zyvox pills! purchase canadian Zyvox, Zyvox in internet no script... Zyvox 600 mg cr overnight fed ex! Zyvox usp... Zyvox ds safety? buy ... [Published Student Village - Sep 28 2014]
Entities: Zyvox, Cheap, MasterCard Inc
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Linezolid Contributes to “Clinical Success” in MRSA Pneumonia

Veterans with methicillin-resistant Staphylococcus aureus (MRSA) pneumonia who were treated with linezolid were 53% more likely to be discharged as “clinical successes,” according to researchers from... ... [Published Federal Practitioner - Sep 23 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Antimicrobials

The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to ... [Published Free Patents Online - Sep 23 2014]

Quotes

"This Attorney General's office has consistently protected Missouri consumers from fraud, regardless of the identity of those responsible."
"All I want to say is this: the government needs to prioritise people over the profits of pharmaceutical companies. Why should my family be broken up for the sake of their balance sheet?" Subscribe to our features-packed weekly newsletter
Dalvance was approved by the FDA as "the first and only intravenous antibiotic for acute bacterial skin and skin structure infections (ABSSSI) with once-a-week dosing for two weeks" according to Actavis, which notes it is also under regulatory review in Europe and could be approved there in 2015
"Our medical review team did discuss the treatment choice with the treating doctor after receiving this request," said Broomberg. "We were however not provided with all the clinical data required to justify approval of extended treatment with Linezolid beyond the initial 28 days."

More Content

All (27) | News (24) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Attorney General's office counters claims by Ne... [Published KOMU - Oct 30 2014]
Two New Antibiotics Treat Severe Skin Infections [Published American Journal of Nursing - Oct 30 2014]
Market Update (NYSE:PFE): Pfizer’s PRISTIQ® (de... [Published Jutia Group - Oct 29 2014]
Pfizer Inc.'s Earnings: Emerging Market Growth ... [Published Motley Fool Discussion Boards - Oct 29 2014]
Pfizer Q3 net income up 3%, guidance updated [Published Seeking Alpha - Oct 28 2014]
Company Update (NYSE:PFE): Pfizer Declares 26-C... [Published Jutia Group - Oct 24 2014]
The battle against Big Pharma for cheap drugs [Published MediaClubSouthAfrica.com - Oct 22 2014]
Stock Update (NYSE:PFE): FDA panel votes to kee... [Published Jutia Group - Oct 17 2014]
This Man’s Simple System Could Transform Americ... [Published Wired News - Oct 14 2014]
Stock Update (NYSE:PFE): Pfizer Announces FDA A... [Published Jutia Group - Oct 13 2014]
Actavis buys infectious disease specialist Durata [Published PMLive - Oct 07 2014]
Actavis expands antibiotics [Published Yahoo! Finance - Oct 07 2014]
South Africa: XDR-TB Patients Smuggle Pills As ... [Published AllAfrica.com - Oct 06 2014]
PANACEA BIOTEC : Patent Issued for Antimicrobials [Published 4 Traders - Oct 04 2014]
Patients break law to get TB drug [Published IOL - Oct 02 2014]
Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer An... [Published Jutia Group - Sep 30 2014]
purchas Desyrel, Desyrel order, Desyrel next da... [Published Student Village - Sep 28 2014]
buy Zyvox no rx, Zyvox where to buy, Zyvox with... [Published Student Village - Sep 28 2014]
Chloramphenicol to buy, generic Chloramphenicol... [Published Student Village - Sep 28 2014]
Linezolid Contributes to “Clinical Success” in ... [Published Federal Practitioner - Sep 23 2014]
Antimicrobials [Published Free Patents Online - Sep 23 2014]
Pfizer net earnings dips by 79% in Q2 to $2,912... [Published PharmaBiz - Jul 30 2014]
7 Companies That Attempted to Silence Whistlebl... [Published Wall St. Cheat Sheet - Jun 19 2014]
Will Pfizer Try Again for AstraZeneca? [Published Wall St. Cheat Sheet - May 21 2014]
Despite Generic Vancomycin's Continued Dominanc... [Published PR Newswire: Health - May 06 2014]
Pfizer's Double Disappointment a Good Buying Op... [Published The Street Latest - May 05 2014]
The Zacks Analyst Blog Highlights:MannKind, Cub... [Published PR Newswire - Apr 10 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
7 Companies That Attempted to Silence Whistlebl... [Published Wall St. Cheat Sheet - Jun 19 2014]
Source: http://www.flickr.com/photos/stevendepolo/ Names like Daniel Ellsworth, Edward Snowden, and Julian Assange have become forever etched in the American lexicon. These individuals, along with troves of others, have single-handedly been able ...
Will Pfizer Try Again for AstraZeneca? [Published Wall St. Cheat Sheet - May 21 2014]
Source: Getty Images There is a misconception among investors that Pfizer ( NYSE:PFE ) was only trying to acquire AstraZeneca ( NYSE:AZN ) to gain access to a country with a corporate tax rate of 21 percent, far lower than the 35 percent rate ...
Despite Generic Vancomycin's Continued Dominanc... [Published PR Newswire: Health - May 06 2014]
BURLINGTON, Mass., May 6, 2014 /PRNewswire/ -- Decision Resources Group finds that overall, infectious disease (ID) specialists and non-ID physicians (critical care and internal medicine specialists) prefer the branded agents Cubist's Cubicin (daptomycin) ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.